Faster FDA Drug Reviews Should Benefit Cardium Therapeutics and CytRx Corporation
NEW YORK, NY-- - It has been a banner year already for the biotechnology sector with new chemical and molecular entity approvals reaching a 20-year high. Additionally, FDA officials claim drug applications ...

A.M. Vitals: Medivation, Astellas Pharma Report Positive Prostate-Drug Results
Also: FDA approvals up; cooperating with the Chinese to make sure food imports are safe.

Why The FDA's Rejection Of Avastin Is Good For Medical Innovation
FDA Commissioner Margaret Hamburg The Food and Drug Administration has decided to revoke the approval of the cancer drug Avastin to treat metastatic breast cancer after a lengthy procedural battle with the drug's maker, Roche. Will that decision hurt the drug industry? Far from it. Avastin was approved for metastatic breast cancer [...]